UCSF Health and UCSF Dentistry, both based in San Francisco, have merged medical and oral health records into its Epic EHR system.
Category: ROOT
Children's hospitals still under pressure as RSV peak nears
Many children’s hospitals are still grappling with capacity challenges amid an influx of patients with respiratory illnesses, even as the surge in respiratory syncytial virus appears to be slowing in some parts of the U.S.
Employee inappropriately accesses UC Davis' EHR for 5 years
An employee of Sacramento, Calif.-based UC Davis Health accessed the health system’s electronic health records system without proper cause, potentially compromising the personal information of 408 patients.
New Jersey ASC 1st in state to debut robot
Dr. Lee Pressler, and Joseph Steinberg, MD, became the first physicians in New Jersey to use Focal One’s new ultrasound robot at Morristown Medical Center Health Pavilion in Rockaway, N.J., according to a Dec. 6 report from NJBiz.
15 physician specialties that saw higher wages in 2022
Plastic surgeons saw the largest wage growth between 2021 and 2022, according to data from Medscape’s 2021 and 2022 Physician Compensation reports.
Connecticut hospital nurses resolve nearly year-long labor dispute
Members of the Windham Federation of Professional Nurses have approved a new contract with their employer that resolves a nearly year-long labor dispute.
How oncologists can reduce suicide risk in prostate cancer patients
Men with prostate cancer are at increased risk of mental distress and suicide, but their oncologists can help, MedPageToday reported Dec. 6.
Physician-led cardiology management org gains 3 Arizona practices
Southwest Cardiovascular Associates has joined Cardiovascular Associates of America (CVAUSA), a physician-led, national network. This partnership marks CVAUSA’s first offerings in Arizona with locations in Mesa, Prescott and Yuma.
Modified vaccines less effective against new variants, 2 studies show
Two studies have found the omicron booster to be lacking when it comes to its strength against new COVID-19 subvariants BQ.1.1, XBB and BA.2.75.2 — which, together, account for 38 percent of cases.
Pfizer eyes the next COVID-19 drug
As other COVID-19 drugs stumble in efficacy as the virus evolves, Pfizer and Cambridge, Mass.-based biotech startup Clear Creek Bio have partnered to develop a new treatment.
